🇺🇸 FDA
Patent

US 12076397

Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration

granted A61KA61K2039/54A61K2039/541

Quick answer

US patent 12076397 (Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/54, A61K2039/541, A61K2039/55566, A61K2039/57